Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Jetstar to Charge for Overhead Cabin Bags From February 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
LAGUNA HILLS, Calif., March 19, 2018 -- Sonendo® Inc., whose GentleWave® System is revolutionizing dentistry and endodontics, announced today that it will present an overview of the company’s progress at the upcoming Needham Healthcare Conference in New York, NY on Tuesday, March 27, 2018, at 12:45 p.m. Eastern Time.
The Company’s presentation, to be delivered by Sonendo’s President and CEO Bjarne Bergheim, will spotlight the advantages GentleWave technology offers over standard root canal treatments. According to Mr. Bergheim, “As more and more endodontists are integrating the GentleWave® System into their practices, they are reporting impressive results that patients truly appreciate. We look forward to the opportunity to present the advantages of the GentleWave System and how it is changing the way root canal therapy is being performed.”
About Sonendo
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to standard root canal techniques.1,2
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact:
Bob Guyatt
Vice President of Marketing
949.766.3636
